menu search

CELC / Celcuity's (CELC) CEO Brian Sullivan on Q4 2021 Results - Earnings Call Transcript

Celcuity's (CELC) CEO Brian Sullivan on Q4 2021 Results - Earnings Call Transcript
Celcuity's (CELC) CEO Brian Sullivan on Q4 2021 Results - Earnings Call Transcript Read More
Posted: Mar 23 2022, 21:28
Author Name: Seeking Alpha
Views: 112038

CELC News  

Celcuity To Present at Upcoming Stifel and Jefferies Investor Conferences

By GlobeNewsWire
November 1, 2023

Celcuity To Present at Upcoming Stifel and Jefferies Investor Conferences

MINNEAPOLIS, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted t more_horizontal

Celcuity Inc. (CELC) Q1 2023 Earnings Call Transcript

By Seeking Alpha
May 15, 2023

Celcuity Inc. (CELC) Q1 2023 Earnings Call Transcript

Celcuity Inc. (NASDAQ:CELC ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Robert Uhl - ICR Westwicke, IR Brian Sulliv more_horizontal

Celcuity Inc. Schedules Release of First Quarter 2023 Financial Results and Webcast/Conference Call

By Accesswire
May 8, 2023

Celcuity Inc. Schedules Release of First Quarter 2023 Financial Results and Webcast/Conference Call

MINNEAPOLIS, MN / ACCESSWIRE / May 8, 2023 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on development of targeted th more_horizontal

Celcuity Inc. (CELC) Q4 2022 Earnings Call Transcript

By Seeking Alpha
March 23, 2023

Celcuity Inc. (CELC) Q4 2022 Earnings Call Transcript

Celcuity Inc. (NASDAQ:CELC ) Q4 2022 Earnings Conference Call March 23, 2023 4:30 PM ET Company Participants Robert Uhl - ICR Westwicke, IR Brian Sull more_horizontal

Celcuity to Present Preclinical Data on Therapeutic Effects of Gedatolisib in Gynecological Cancer Models at AACR Annual Meeting 2023

By Accesswire
March 15, 2023

Celcuity to Present Preclinical Data on Therapeutic Effects of Gedatolisib in Gynecological Cancer Models at AACR Annual Meeting 2023

MINNEAPOLIS, MN / ACCESSWIRE / March 15, 2023 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on development of targeted more_horizontal

Celcuity Inc. (CELC) Q3 2022 Earnings Call Transcript

By Seeking Alpha
November 13, 2022

Celcuity Inc. (CELC) Q3 2022 Earnings Call Transcript

Celcuity Inc. (NASDAQ:CELC ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Robert Uhl - ICR Westwicke Brian Sulli more_horizontal

Celcuity Inc. Schedules Release of Third Quarter 2022 Financial Results and Webcast/Conference Call

By Accesswire
November 3, 2022

Celcuity Inc. Schedules Release of Third Quarter 2022 Financial Results and Webcast/Conference Call

MINNEAPOLIS, MN/ ACCESSWIRE / November 3, 2022 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on development of targete more_horizontal

Can Celcuity, Inc. (CELC) Climb 462% to Reach the Level Wall Street Analysts Expect?

By Zacks Investment Research
May 30, 2022

Can Celcuity, Inc. (CELC) Climb 462% to Reach the Level Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 461.9% in Celcuity, Inc. (CELC). While the effectiveness of t more_horizontal


Search within

Pages Search Results: